132 related articles for article (PubMed ID: 1964226)
1. Structure-activity study of neurokinins: antagonists for the neurokinin-2 receptor.
Dion S; Rouissi N; Nantel F; Jukic D; Rhaleb NE; Tousignant C; Télémaque S; Drapeau G; Regoli D; Naline E
Pharmacology; 1990; 41(4):184-94. PubMed ID: 1964226
[TBL] [Abstract][Full Text] [Related]
2. Neurokinin receptors antagonists: old and new.
Jukic D; Rouissi N; Laprise R; Boussougou M; Regoli D
Life Sci; 1991; 49(20):1463-9. PubMed ID: 1719324
[TBL] [Abstract][Full Text] [Related]
3. Competitive antagonists discriminate between NK2 tachykinin receptor subtypes.
Maggi CA; Patacchini R; Giuliani S; Rovero P; Dion S; Regoli D; Giachetti A; Meli A
Br J Pharmacol; 1990 Jul; 100(3):589-92. PubMed ID: 2167737
[TBL] [Abstract][Full Text] [Related]
4. Antagonists for the neurokinin NK-3 receptor evaluated in selective receptor systems.
Drapeau G; Rouissi N; Nantel F; Rhaleb NE; Tousignant C; Regoli D
Regul Pept; 1990 Nov; 31(2):125-35. PubMed ID: 2176308
[TBL] [Abstract][Full Text] [Related]
5. Affinity of R 396, an NK-2 tachykinin receptor antagonist, for NK-2 receptors in preparations from different species.
Maggi CA; Patacchini R; Astolfi M; Rovero P; Giachetti A; Van Giersbergen PL
Neuropeptides; 1992 Jun; 22(2):93-8. PubMed ID: 1328923
[TBL] [Abstract][Full Text] [Related]
6. Characterization of neurokinin receptors in various isolated organs by the use of selective agonists.
Dion S; D'Orléans-Juste P; Drapeau G; Rhaleb NE; Rouissi N; Tousignant C; Regoli D
Life Sci; 1987 Nov; 41(20):2269-78. PubMed ID: 2824947
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological receptors for substance P and neurokinins.
Regoli D; Drapeau G; Dion S; D'Orléans-Juste P
Life Sci; 1987 Jan; 40(2):109-17. PubMed ID: 2432376
[TBL] [Abstract][Full Text] [Related]
8. [Leu9 psi(CH2NH)Leu10]-neurokinin A (4-10) (MDL 28,564) distinguishes tissue tachykinin peptide NK2 receptors.
Buck SH; Harbeson SL; Hassmann CF; Shatzer SA; Rouissi N; Nantel F; van Giersbergen PL
Life Sci; 1990; 47(10):PL37-41. PubMed ID: 2170788
[TBL] [Abstract][Full Text] [Related]
9. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
10. Selective agonists for receptors of substance P and related neurokinins.
Regoli D; Dion S; Rhaleb NE; Rouissi N; Tousignant C; Jukic D; D'Orleans-Juste P; Drapeau G
Biopolymers; 1989 Jan; 28(1):81-90. PubMed ID: 2470440
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of dimeric analogs of neurokinin A and B: effect of dimerization of COOH-terminal heptapeptides on receptor selection.
Sakaguchi K; Kodama H; Matsumoto H; Yoshida M; Takano Y; Kamiya H; Waki M; Shimohigashi Y
Pept Res; 1989; 2(5):345-51. PubMed ID: 2485210
[TBL] [Abstract][Full Text] [Related]
12. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA
Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319
[TBL] [Abstract][Full Text] [Related]
13. N-terminal truncated analogs of men 10376 as tachykinin NK-2 receptor antagonists.
Quartara L; Patacchini R; Giuliani S; Renzetti AR; Rovero P; Maggi CA
Life Sci; 1992; 51(25):1929-36. PubMed ID: 1333561
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of bradykinin and related peptides. B2-receptor antagonists.
Rhaleb NE; Télémaque S; Rouissi N; Dion S; Jukic D; Drapeau G; Regoli D
Hypertension; 1991 Jan; 17(1):107-15. PubMed ID: 1846119
[TBL] [Abstract][Full Text] [Related]
15. Neurokinins produce selective venoconstriction via NK-3 receptors in the rat mesenteric vascular bed.
D'Orléans-Juste P; Claing A; Télémaque S; Warner TD; Regoli D
Eur J Pharmacol; 1991 Nov; 204(3):329-34. PubMed ID: 1723050
[TBL] [Abstract][Full Text] [Related]
16. Receptors for neurokinins in human bronchus and urinary bladder are of the NK-2 type.
Dion S; Rouissi N; Nantel F; Drapeau G; Regoli D; Naline E; Advenier C
Eur J Pharmacol; 1990 Mar; 178(2):215-9. PubMed ID: 1691713
[TBL] [Abstract][Full Text] [Related]
17. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
Patacchini R; Quartara L; Rovero P; Goso C; Maggi CA
J Pharmacol Exp Ther; 1993 Jan; 264(1):17-21. PubMed ID: 8380857
[TBL] [Abstract][Full Text] [Related]
18. Specific agonists for neurokinin B receptors.
Drapeau G; d'Orléans-Juste P; Dion S; Rhaleb NE; Regoli D
Eur J Pharmacol; 1987 Apr; 136(3):401-3. PubMed ID: 3038572
[TBL] [Abstract][Full Text] [Related]
19. Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor.
McElroy AB; Clegg SP; Deal MJ; Ewan GB; Hagan RM; Ireland SJ; Jordan CC; Porter B; Ross BC; Ward P
J Med Chem; 1992 Jul; 35(14):2582-91. PubMed ID: 1321907
[TBL] [Abstract][Full Text] [Related]
20. Selective agonists for substance P and neurokinin receptors.
Drapeau G; D'Orléans-Juste P; Dion S; Rhaleb NE; Rouissi NE; Regoli D
Neuropeptides; 1987 Jul; 10(1):43-54. PubMed ID: 2444902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
